Transpharma-Medical Receives Second Milestone Payment from Teva Pharmaceutical Industries Limited (TEVA)  
6/13/2007 12:10:35 PM

LOD, ISRAEL, June 11, 2007 - TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today it has received its second milestone payment from Teva Pharmaceutical Industries for the successful development of a stable human growth hormone (hGH) dry form patch required for advanced clinical trials of Teva’s transdermal hGH product.